BSECompany Update30 Oct 2026 · 30 Oct 2026, 11:11 am
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on September 30, 2026.
Lincoln Pharmaceuticals Ltd · 531633
✦ AI SummaryResults
Lincoln Pharmaceuticals Ltd has announced the publication of its un-audited financial results for the quarter and half year ended September 30, 2026, as required by Regulation 47 of SEBI (LODR) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication